There is a situation familiar to a significant number of the world's most successful individuals: a balance sheet that reflects extraordinary wealth — tens or hundreds of millions of dollars in publicly traded stock — alongside a genuine difficulty accessing liquid capital for a new opportunity, a real estate acquisition, or a strategic investment.

This is the liquidity paradox. And in 2026, as equity markets have grown more volatile, as geopolitical risks have multiplied, and as the pace of international investment opportunities has accelerated, it is a paradox that more shareholders are confronting.

How It Happens

The path to a concentrated equity position is rarely accidental. A founder takes a company public and retains a significant stake. An executive accumulates shares through decades of equity compensation. A family holds a multigenerational position in a publicly traded business. An early investor whose conviction proved correct now holds a position that represents the majority of their net worth.

In each case, the position reflects success. It also creates a specific and often underappreciated problem: selling feels wrong — and in many circumstances, it is wrong.

For an executive subject to trading windows and Rule 144 restrictions, selling may not even be possible on a desired timeline. For a founder who built a company over twenty years, selling even a fraction of their stake sends a signal to the market that can move prices. For a family office managing multigenerational wealth, liquidating a position that has compounded for decades creates a capital gains event that can consume a significant portion of the realized proceeds.

The Cost of Selling

In 2026, for shareholders in many jurisdictions, the combined cost of realizing a long-held gain — including federal capital gains tax, state taxes where applicable, and the net investment income tax — can represent thirty to fifty percent of the appreciated value, depending on holding period and jurisdiction. For international shareholders, the tax picture varies but rarely favors an early exit from an appreciated position.

Beyond the tax cost, there is the opportunity cost. A founder who sells their stake to fund a real estate acquisition has permanently exited a position that may continue to appreciate. The capital deployed into real estate now competes with the foregone return of the original holding.

There is also reputational and signaling risk. An executive whose stock sales are publicly disclosed creates uncertainty among other investors. Even when the sale is motivated by personal financial planning rather than concerns about the company, the market may interpret it differently.

A Different Approach

The structure that resolves this paradox has existed in institutional lending for decades, though it remains less understood than it should be outside of private banking circles: the non-recourse stock loan.

In a non-recourse stock loan, the shareholder pledges a portion of their publicly traded equity as collateral and receives a loan — typically up to seventy percent of the position's value — without selling a single share. The loan is non-recourse, meaning the lender's only claim in a default scenario is against the pledged shares themselves. The borrower's other assets — real estate, other investments, business interests — are not pledged and remain entirely separate.

Critically, the borrower retains ownership of the pledged shares for the duration of the loan. Dividends, voting rights, and participation in any appreciation remain with the shareholder. The loan does not trigger a taxable event. And because the facility is asset-secured rather than credit-assessed, there is no personal income verification, no credit review, and no requirement to disclose the borrowing to other lenders or business partners.

Who This Is For

The structure is not appropriate for every shareholder. The security must be publicly traded on a recognized exchange, with sufficient market capitalization and average daily trading volume to satisfy underwriting requirements. Positions must meet a minimum threshold — typically $1,000,000 or more in value. And the borrower must be comfortable with the mechanics of a pledged collateral arrangement and its implications over the loan term.

For those who do qualify, however, the non-recourse stock loan addresses the liquidity paradox directly: it makes the value of a concentrated position available as working capital, without the tax cost, the market signal, or the permanent exit from a position the holder may have spent years building.

Stone Creek Global has arranged these facilities for shareholders across 195 countries and 80 exchanges since 2007, with transactions ranging from $1,000,000 to well in excess of $1,000,000,000. All engagements are handled with complete confidentiality.

Explore whether a stock loan may be appropriate for your situation.

All consultations are confidential and obligation-free. We work with shareholders, founders, executives, family offices, and their advisors across 195 countries.

Request a Confidential Consultation